Impact of a Moderate CYP3A4 Inducer (bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: an Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study
Pharmaceuticals（2024）
关键词
drug-drug interaction,bosentan,pharmacokinetics,lurbinectedin,cancer patients,advanced solid tumors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要